NO2849744T3 - - Google Patents
Info
- Publication number
- NO2849744T3 NO2849744T3 NO13723003A NO13723003A NO2849744T3 NO 2849744 T3 NO2849744 T3 NO 2849744T3 NO 13723003 A NO13723003 A NO 13723003A NO 13723003 A NO13723003 A NO 13723003A NO 2849744 T3 NO2849744 T3 NO 2849744T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12003937 | 2012-05-18 | ||
| PCT/EP2013/001464 WO2013170965A1 (en) | 2012-05-18 | 2013-05-16 | Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and antidepressants |
| EP13723003.3A EP2849744B1 (en) | 2012-05-18 | 2013-05-16 | Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and duloxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2849744T3 true NO2849744T3 (no) | 2018-04-21 |
Family
ID=48446243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO13723003A NO2849744T3 (no) | 2012-05-18 | 2013-05-16 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20130310385A1 (no) |
| EP (1) | EP2849744B1 (no) |
| JP (1) | JP6116672B2 (no) |
| CN (1) | CN104271131A (no) |
| AU (1) | AU2013262071B2 (no) |
| BR (1) | BR112014028562A2 (no) |
| CA (1) | CA2873634A1 (no) |
| CY (1) | CY1119825T1 (no) |
| DK (1) | DK2849744T3 (no) |
| EA (1) | EA027268B1 (no) |
| ES (1) | ES2660461T3 (no) |
| HK (1) | HK1204944A1 (no) |
| HR (1) | HRP20171922T1 (no) |
| HU (1) | HUE037746T2 (no) |
| IL (1) | IL235657B (no) |
| LT (1) | LT2849744T (no) |
| MX (1) | MX354684B (no) |
| NO (1) | NO2849744T3 (no) |
| PL (1) | PL2849744T3 (no) |
| PT (1) | PT2849744T (no) |
| RS (1) | RS56856B1 (no) |
| SI (1) | SI2849744T1 (no) |
| WO (1) | WO2013170965A1 (no) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10022353B2 (en) | 2015-01-23 | 2018-07-17 | Grünenthal GmbH | Cebranopadol for treating pain in subjects with impaired hepatic and/or impaired renal function |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0068838B1 (en) | 1981-06-26 | 1986-09-17 | The Upjohn Company | Analgesic process and composition |
| US4389393A (en) | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US4404208A (en) | 1982-06-30 | 1983-09-13 | E. I. Du Pont De Nemours And Company | Analgesic mixture of nalbuphine and tiflamizole |
| US4783337A (en) | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
| US4765989A (en) | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| US4612008A (en) | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
| ATE46265T1 (de) | 1985-01-23 | 1989-09-15 | Asta Pharma Ag | Synergistische kombination von flupirtin und nicht-steroidalen antiphlogistika. |
| EP0473655B1 (en) | 1989-05-22 | 1997-01-15 | Biochemical Veterinary Research Pty. Ltd. | Divalent metal salts of indomethacin |
| US5708035A (en) * | 1991-02-04 | 1998-01-13 | Sepracor Inc. | Methods of use and compositions of R(-) fluoxetine |
| AU662160B2 (en) | 1991-07-04 | 1995-08-24 | Taisho Pharmaceutical Co., Ltd. | Analgesic |
| JPH05221857A (ja) | 1992-02-14 | 1993-08-31 | Arakusu:Kk | 配合解熱鎮痛剤 |
| US5472711A (en) | 1992-07-30 | 1995-12-05 | Edward Mendell Co., Inc. | Agglomerated hydrophilic complexes with multi-phasic release characteristics |
| US5330761A (en) | 1993-01-29 | 1994-07-19 | Edward Mendell Co. Inc. | Bioadhesive tablet for non-systemic use products |
| EP0702681A1 (en) | 1993-06-07 | 1996-03-27 | Merck & Co. Inc. | Spiro-substituted azacycles as neurokinin antagonists |
| US5455046A (en) | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
| US5399362A (en) | 1994-04-25 | 1995-03-21 | Edward Mendell Co., Inc. | Once-a-day metoprolol oral dosage form |
| US20030056896A1 (en) | 1995-05-12 | 2003-03-27 | Frank Jao | Effective therapy for epilepsies |
| US5914129A (en) | 1996-07-23 | 1999-06-22 | Mauskop; Alexander | Analgesic composition for treatment of migraine headaches |
| RS49982B (sr) | 1997-09-17 | 2008-09-29 | Euro-Celtique S.A., | Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2 |
| CA2343148C (en) | 1998-09-10 | 2005-11-15 | Nycomed Danmark A/S | Quick release pharmaceutical compositions of drug substances |
| EP1135121B1 (en) | 1998-11-13 | 2003-03-12 | Eli Lilly And Company | Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain |
| US6117900A (en) | 1999-09-27 | 2000-09-12 | Asta Medica Aktiengesellschaft | Use of retigabine for the treatment of neuropathic pain |
| WO2002026714A1 (fr) | 2000-09-27 | 2002-04-04 | Takeda Chemical Industries, Ltd. | Composes spiraniques |
| DE50104197D1 (de) | 2000-12-28 | 2004-11-25 | Fresenius Kabi Austria Gmbh Gr | Stabile Infusionslösung von Diclofenac-Salzen, deren Herstellung und Verwendung |
| JP2005519921A (ja) | 2002-01-28 | 2005-07-07 | ファイザー株式会社 | Ｏｒｌ−１受容体リガンドとしてのｎ置換スピロピペリジン化合物 |
| ES2286177T3 (es) | 2002-06-17 | 2007-12-01 | Chiesi Farmaceutici S.P.A. | Procedimiento para la preparacion de piroxicam: compuestos de inclusion de betaciclodextrina. |
| US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
| DE10252667A1 (de) * | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| CN1717237A (zh) | 2002-11-26 | 2006-01-04 | 艾利斯达分子传输公司 | 洛沙平和阿莫沙平在制备治疗疼痛的药物中的应用 |
| DE10257824B4 (de) | 2002-12-10 | 2004-11-11 | Kochem, Hans-Günter, Dr. | Zusammensetzung zur Schmerzbehandlung, insbesondere zur Behandlung von Gelenkschmerzen |
| US20100297252A1 (en) | 2003-03-03 | 2010-11-25 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
| US7132452B2 (en) | 2003-03-10 | 2006-11-07 | Fang-Yu Lee | Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection |
| US20040222123A1 (en) | 2003-05-06 | 2004-11-11 | Barr Laboratories, Inc. | Kit for pharmaceuticals |
| CN1245379C (zh) | 2003-10-30 | 2006-03-15 | 曹桂东 | 加巴喷丁的制法 |
| DE10360792A1 (de) * | 2003-12-23 | 2005-07-28 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| GB0412878D0 (en) * | 2004-06-09 | 2004-07-14 | Pfizer Ltd | Use |
| KR20070029740A (ko) | 2004-06-09 | 2007-03-14 | 화이자 인코포레이티드 | 통증 치료를 위한 레복세틴의 용도 |
| CA2612299A1 (en) | 2005-06-17 | 2006-12-21 | Pfizer Inc. | Alpha-(aryl-or heteroaryl-methyl)-beta piperidino propanamide compounds as orl1-receptor antagonists |
| US8093408B2 (en) * | 2005-06-21 | 2012-01-10 | The Company Wockhardt | Antidepressant oral pharmaceutical compositions |
| PL2012763T3 (pl) | 2006-04-28 | 2011-08-31 | Gruenenthal Gmbh | Kombinacja farmaceutyczna zawierająca 3-(3-dimetyloamino-1-etylo-2-metylo-propylo)-fenol i NSAID |
| CA2650423C (en) | 2006-04-28 | 2014-08-12 | Gruenenthal Gmbh | Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and paracetamol |
| US20080014264A1 (en) | 2006-07-13 | 2008-01-17 | Ucb, S.A. | Novel pharmaceutical compositions comprising levetiracetam |
| CN101147735A (zh) | 2006-09-19 | 2008-03-26 | 沈阳华泰药物研究有限公司 | 注射用药物组合物及其药盒 |
| DE102006046745A1 (de) | 2006-09-29 | 2008-04-03 | Grünenthal GmbH | Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz |
| JP2008106028A (ja) | 2006-10-26 | 2008-05-08 | Boehringer Ingelheim Internatl Gmbh | 慢性疼痛の治療におけるフリバンセリンの使用 |
| DE102006056458A1 (de) | 2006-11-28 | 2008-05-29 | Grünenthal GmbH | Arzneimittelzubereitung von Tramadol und Acetaminophen |
| US20080153874A1 (en) | 2006-12-22 | 2008-06-26 | Allergan Inc. | Alpha-2b receptor agonist and anticonvulsant compositions for treating chronic pain |
| WO2008108639A1 (en) | 2007-03-08 | 2008-09-12 | Avantium Holding B.V. | Co-crystalline forms of carbamazepine |
| EP1977744A1 (en) | 2007-04-03 | 2008-10-08 | Chemo Ibérica, S.A. | Polymorphic Form alpha of (S)-Pregabalin and process for its preparation |
| EP2207569B1 (en) | 2007-10-09 | 2013-03-27 | Merck Patent GmbH | Pharmaceutical compositions containing benfotiamine and one or more pharmaceutically active agents for the treatment of pain conditions of neuropathic origin |
| WO2009083115A1 (de) | 2007-12-21 | 2009-07-09 | Paz Arzneimittel-Entwicklungsgesellschaft Mbh | Arzneimittel sowie deren herstellung und verwendung bei der behandlung von schmerzhaften neuropathien |
| EP2123626A1 (en) * | 2008-05-21 | 2009-11-25 | Laboratorios del Dr. Esteve S.A. | Co-crystals of duloxetine and co-crystal formers for the treatment of pain |
| EP2297092A1 (en) | 2008-05-28 | 2011-03-23 | Pliva Hrvatska D.O.O. | Polymorphic and amorphous forms of lacosamide and amorphous compositions |
| CN100560061C (zh) | 2008-06-20 | 2009-11-18 | 海南锦瑞制药股份有限公司 | 一种氯诺昔康冻干粉针剂及其制备方法 |
| KR20110059634A (ko) | 2008-09-05 | 2011-06-02 | 그뤼넨탈 게엠베하 | 6-디메틸아미노메틸-1-(3-메톡시-페닐)-사이클로헥산-1,3디올 및 파라세타몰을 포함하는 약제학적 병용물 |
| DK2331210T3 (da) | 2008-09-05 | 2014-08-11 | Gruenenthal Gmbh | Farmaceutisk kombination af 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol og et antiepileptika |
| RU2011112445A (ru) | 2008-09-05 | 2012-10-10 | Грюненталь ГмбХ (DE) | Фармацевтическая комбинация, которая содержит 6-диметиламинометил-1-(3-метоксифенил)-циклогексан-1,3-диол и нпвс |
| DE102009013613A1 (de) | 2009-03-17 | 2010-09-23 | Ratiopharm Gmbh | Trockenverarbeitung von Retigabin |
| RU2544552C2 (ru) | 2010-07-30 | 2015-03-20 | Торэй Индастриз, Инк. | Терапевтическое средство или профилактическое средство для нейропатической боли |
| CN103153282B (zh) * | 2010-08-04 | 2015-08-19 | 格吕伦塔尔有限公司 | 含6’-氟-(n-甲基-或n,n-二甲基-)-4-苯基-4’,9’-二氢-3’h-螺[环己烷-1,1’-吡喃并[3,4,b]吲哚]-4-胺的药物剂型 |
| PE20131096A1 (es) * | 2010-08-04 | 2013-10-10 | Gruenenthal Chemie | Forma de dosificacion farmaceutica que comprende 6'-fluoro-(n-metil-o n,n-dimetil)-4-fenil-4',9-dihidro-3'h-espiro[ciclohxan-1,1'-pirano[3,4,b]indol]-4-amina para el tratamiento de dolor neuropatico |
| AR082561A1 (es) * | 2010-08-04 | 2012-12-19 | Gruenenthal Gmbh | Forma de dosificacion farmaceutica que comprende 6’-fluoro-(n-metil- o n,n-dimetil)-4-fenil-4’,9’-dihidro-3’h-espiro[ciclohexan-1,1’-pirano[3,4,b]indol]-4-amina |
| US9320729B2 (en) | 2012-05-18 | 2016-04-26 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative |
-
2013
- 2013-05-13 US US13/892,803 patent/US20130310385A1/en not_active Abandoned
- 2013-05-16 AU AU2013262071A patent/AU2013262071B2/en not_active Ceased
- 2013-05-16 NO NO13723003A patent/NO2849744T3/no unknown
- 2013-05-16 RS RS20180143A patent/RS56856B1/sr unknown
- 2013-05-16 PL PL13723003T patent/PL2849744T3/pl unknown
- 2013-05-16 ES ES13723003.3T patent/ES2660461T3/es active Active
- 2013-05-16 EP EP13723003.3A patent/EP2849744B1/en active Active
- 2013-05-16 HU HUE13723003A patent/HUE037746T2/hu unknown
- 2013-05-16 WO PCT/EP2013/001464 patent/WO2013170965A1/en active Application Filing
- 2013-05-16 MX MX2014012859A patent/MX354684B/es active IP Right Grant
- 2013-05-16 CN CN201380025639.9A patent/CN104271131A/zh active Pending
- 2013-05-16 JP JP2015511951A patent/JP6116672B2/ja active Active
- 2013-05-16 LT LTEP13723003.3T patent/LT2849744T/lt unknown
- 2013-05-16 DK DK13723003.3T patent/DK2849744T3/en active
- 2013-05-16 PT PT137230033T patent/PT2849744T/pt unknown
- 2013-05-16 BR BR112014028562A patent/BR112014028562A2/pt not_active IP Right Cessation
- 2013-05-16 SI SI201330895T patent/SI2849744T1/en unknown
- 2013-05-16 CA CA2873634A patent/CA2873634A1/en not_active Abandoned
- 2013-05-16 EA EA201401269A patent/EA027268B1/ru not_active IP Right Cessation
-
2014
- 2014-11-12 IL IL235657A patent/IL235657B/en active IP Right Grant
-
2015
- 2015-06-11 HK HK15105575.5A patent/HK1204944A1/xx not_active IP Right Cessation
-
2016
- 2016-09-22 US US15/272,979 patent/US10328055B2/en not_active Expired - Fee Related
-
2017
- 2017-12-12 HR HRP20171922TT patent/HRP20171922T1/hr unknown
-
2018
- 2018-01-24 CY CY20181100091T patent/CY1119825T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013262071B2 (en) | 2018-01-18 |
| JP2015520154A (ja) | 2015-07-16 |
| US20170065560A1 (en) | 2017-03-09 |
| RS56856B1 (sr) | 2018-04-30 |
| WO2013170965A1 (en) | 2013-11-21 |
| EA027268B1 (ru) | 2017-07-31 |
| US10328055B2 (en) | 2019-06-25 |
| EA201401269A1 (ru) | 2016-05-31 |
| PL2849744T3 (pl) | 2018-06-29 |
| HK1204944A1 (en) | 2015-12-11 |
| SI2849744T1 (en) | 2018-01-31 |
| US20130310385A1 (en) | 2013-11-21 |
| LT2849744T (lt) | 2018-02-26 |
| HRP20171922T1 (hr) | 2018-02-09 |
| HUE037746T2 (hu) | 2018-09-28 |
| BR112014028562A2 (pt) | 2017-06-27 |
| PT2849744T (pt) | 2018-02-28 |
| CA2873634A1 (en) | 2013-11-21 |
| AU2013262071A1 (en) | 2015-01-22 |
| MX354684B (es) | 2018-03-15 |
| IL235657B (en) | 2018-08-30 |
| MX2014012859A (es) | 2015-01-19 |
| JP6116672B2 (ja) | 2017-04-19 |
| CN104271131A (zh) | 2015-01-07 |
| EP2849744A1 (en) | 2015-03-25 |
| DK2849744T3 (en) | 2018-01-22 |
| ES2660461T3 (es) | 2018-03-22 |
| CY1119825T1 (el) | 2018-06-27 |
| IL235657A0 (en) | 2015-01-29 |
| EP2849744B1 (en) | 2017-11-22 |